A Phase I Study of Combination Therapy With Didanosine (ddI) and Ribavirin in HIV-Infected Children.
Clinical trial NCT00000833 · COMPLETED
Trial details
- NCT number
- NCT00000833
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.